Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

We are beginning to see early signs of rotations back into more risk-on areas of the equity market -- a bullish sign for the broad market. Short-term outperformance and constructive consolidation/bottoming patterns are evident within biotech (IBB, XBI), small- and micro-caps (IWM, IWC), and emerging markets (EEM). This only adds to our positive outlook for the weeks and months ahead; continue to buy pullbacks.

We are beginning to see early signs of rotations back into more risk-on areas of the equity market -- a bullish sign for the broad market. Short-term outperformance and constructive consolidation/bottoming patterns are evident within biotech (IBB, XBI), small- and micro-caps (IWM, IWC), and emerging markets (EEM). This only adds to our positive outlook for the weeks and months ahead; continue to buy pullbacks.

U.S. Equity Strategy: Risk-On Rotations Vs. Weaker Seasonality; Russell 2000, Biotech, EM Improving

<div>The action we are seeing in broad indexes, Sectors, and in market dynamics continues to support our overall bullish outlook. Additionally, the mild deterioration in market dynamics that we discussed the past two weeks is now much less of a concern. Continue to buy dips. In today’s report we highlight attractive Groups and stocks within Consumer Discretionary, Energy, and Health Care.</div>

The action we are seeing in broad indexes, Sectors, and in market dynamics continues to support our overall bullish outlook. Additionally, the mild deterioration in market dynamics that we discussed the past two weeks is now much less of a concern. Continue to buy dips. In today’s report we highlight attractive Groups and stocks within Consumer Discretionary, Energy, and Health Care.

U.S. Equity Strategy: Bullish Outlook Intact

The S&amp;P 500 remains in a long-term uptrend and a shorter-term, YTD consolidation. The next key resistance level to be tested is the all-time high of 2,873 which was set in January. On the plus side, the Advance-Decline (A-D) line, hit a new all-time high last week. Additionally, cap- and equal-weighted cyclicals vs. staples ratios have given up some ground recently but remain conducive to a risk-on environment.In today’s report we provide a complete U.S. equity strategy overview, and highlight attractive Groups and stocks within the Consumer Discretionary sector, including: auto parts, small-cap apparel, accessory &amp; luxury goods, and off-price retailers.

The S&amp;P 500 remains in a long-term uptrend and a shorter-term, YTD consolidation. The next key resistance level to be tested is the all-time high of 2,873 which was set in January. On the plus side, the Advance-Decline (A-D) line, hit a new all-time high last week. Additionally, cap- and equal-weighted cyclicals vs. staples ratios have given up some ground recently but remain conducive to a risk-on environment.In today’s report we provide a complete U.S. equity strategy overview, and highlight attractive Groups and stocks within the Consumer Discretionary sector, including: auto parts, small-cap apparel, accessory &amp; luxury goods, and off-price retailers.

U.S. Equity Strategy: Opportunities in Retailing Stocks

United States

Oxford Industries, Inc. is an international manufacturer and wholesale marketer of branded and private label apparel for men, women, and children.  The Company's private label customers include national chains, specialty catalogs, mass merchandisers, department stores, specialty stores, and Internet retailers.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Oxford Industries (OXM US)

U.S. Equity Strategy: Risk-On Rotations Vs. Weaker Seasonality; Russell 2000, Biotech, EM Improving

We are seeing signs of rotations back into more risk-on areas of the equity market -- a bullish sign for the broad market. Add to biotech, small-...

Vermilion Research

U.S. Equity Strategy: Bullish Outlook Intact

The action we are seeing in broad indexes, Sectors, and in market dynamics continues to support our overall bullish outlook. Continue to buy dips.

Vermilion Research

U.S. Equity Strategy: Opportunities in Retailing Stocks

The S&P 500 remains in a long-term uptrend and a shorter-term, YTD consolidation. The next key resistance level to be tested is the all-time...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)